UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 110

Sortiert nach

Quality-of-Life Effects of Prostate-Specific Antigen Screening

The New England journal of medicine, 2012-08, Vol.367 (7), p.595-605

2012

Volltextzugriff (PDF)

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer

Proceedings of the National Academy of Sciences - PNAS, 2010-02, Vol.107 (5), p.2136-2140

2010

Volltextzugriff (PDF)

The Relationship between Prostate-Specific Antigen and Prostate Cancer Risk: The Prostate Biopsy Collaborative Group

Clinical cancer research, 2010-09, Vol.16 (17), p.4374-4381

2010

Volltextzugriff (PDF)

Results of a randomized, population‐based study of biennial screening using serum prostate‐specific antigen measurement to detect prostate carcinoma

Cancer, 2004-04, Vol.100 (7), p.1397-1405

2004

Volltextzugriff (PDF)

Post-Radical Prostatectomy Inguinal Hernia: A Simple Surgical Intervention can Substantially Reduce the Incidence—Results From a Prospective Randomized Trial

The Journal of urology, 2010-09, Vol.184 (3), p.984-989

2010

Volltextzugriff (PDF)

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

The New England journal of medicine, 2022-12, Vol.387 (23), p.2126-2137

2022

Volltextzugriff (PDF)

Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at -20 {degrees}C

Clinical chemistry (Baltimore, Md.), 2006-02, Vol.52 (2), p.235-239

2006

Volltextzugriff (PDF)

Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial

The Journal of urology, 2022-08, Vol.208 (2), p.292-300

2022

Volltextzugriff (PDF)

Test Sensitivity in the European Prostate Cancer Screening Trial: Results from Finland, Sweden, and the Netherlands

Cancer epidemiology, biomarkers & prevention, 2009-07, Vol.18 (7), p.2000-2005

2009

Volltextzugriff (PDF)

Prostate Specific Antigen and Biopsy Contamination in the Göteborg-1 Randomized, Population-Based, Prostate Cancer Screening Trial

The Journal of urology, 2022-11, Vol.208 (5), p.1018-1027

2022

Volltextzugriff (PDF)

Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review

Journal of clinical oncology, 2012-07, Vol.30 (21), p.2581-2584

2012

Volltextzugriff (PDF)

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

The Lancet (British edition), 2014-12, Vol.384 (9959), p.2027-2035

2014

Volltextzugriff (PDF)

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

Annals of internal medicine, 2017-10, Vol.167 (7), p.449

2017

Volltextzugriff (PDF)

Long-Term Outcomes after Deferred Radical Prostatectomy in Men Initially Treated with Active Surveillance

The Journal of urology, 2018-10, Vol.200 (4), p.779-785

2018

Volltextzugriff (PDF)

Prostate-Cancer Mortality at 11 Years of Follow-up

The New England journal of medicine, 2012-03, Vol.366 (11), p.981-990

2012

Volltextzugriff (PDF)

1731 HOW SCREENING DOES AFFECT ERECTILE FUNCTION AND URINARY CONTINENCE FOLLOWING RADICAL PROSTATECTOMY - RESULTS FROM THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC)

The Journal of urology, 2010, Vol.183 (4), p.e669-e669

2010

Volltextzugriff (PDF)

The Effect of Start and Stop Age at Screening on the Risk of Being Diagnosed with Prostate Cancer

The Journal of urology, 2016-05, Vol.195 (5), p.1390-1396

2016

Volltextzugriff (PDF)

Results from 22 years of Follow-Up in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial

The Journal of urology, 2022, Vol.208 (2), p.292

2022

Volltextzugriff (PDF)

The dilemmas of prostate cancer screening

Medical journal of Australia, 2013-11, Vol.199 (9), p.583-584

2013

Volltextzugriff (PDF)

Screening and Prostate-Cancer Mortality in a Randomized European Study

The New England journal of medicine, 2009-03, Vol.360 (13), p.1320-1328

2009

Volltextzugriff (PDF)

MP46-02 PROSTATE CANCER SCREENING NOMOGRAM PREDICTING 15-YEAR RISK OF CLINICALLY SIGNIFICANT PROSTATE CANCER, DEVELOPED USING COMPETING RISK ANALYSIS

The Journal of urology, 2018-04, Vol.199 (4), p.e606-e606

2018

Volltextzugriff (PDF)

PD35-04 COULD DIFFERENCES IN TREATMENT BETWEEN TRIAL ARMS EXPLAIN THE REDUCTION IN PROSTATE CANCER MORTALITY IN THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER?

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Volltextzugriff (PDF)

Prospective evaluation of a new patient decision aid to enhance prostate cancer screening decision-making

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.87-87

2019

Volltextzugriff (PDF)

The efficacy of prostate‐specific antigen screening: Impact of key components in the ERSPC and PLCO trials

Cancer, 2018-03, Vol.124 (6), p.1197-1206

2018

Volltextzugriff (PDF)

Thromboembolic Complications in 3,544 Patients Undergoing Radical Prostatectomy with or without Lymph Node Dissection

The Journal of urology, 2015, Vol.193 (1), p.117-125

2015

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Aktive Filter

KollektionSAGE Complete

KollektionPublisher or Other Site

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(109)
Tagungsberichte
(1)

Sprache

Englisch
(110)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quality-of-Life Effects of Prostate-Specific Antigen Screening

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer

The Relationship between Prostate-Specific Antigen and Prostate Cancer Risk: The Prostate Biopsy Collaborative Group

Results of a randomized, population‐based study of biennial screening using serum prostate‐specific antigen measurement to detect prostate carcinoma

Post-Radical Prostatectomy Inguinal Hernia: A Simple Surgical Intervention can Substantially Reduce the Incidence—Results From a Prospective Randomized Trial

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at -20 {degrees}C

Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial

Test Sensitivity in the European Prostate Cancer Screening Trial: Results from Finland, Sweden, and the Netherlands

Prostate Specific Antigen and Biopsy Contamination in the Göteborg-1 Randomized, Population-Based, Prostate Cancer Screening Trial

Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

Long-Term Outcomes after Deferred Radical Prostatectomy in Men Initially Treated with Active Surveillance

Prostate-Cancer Mortality at 11 Years of Follow-up

1731 HOW SCREENING DOES AFFECT ERECTILE FUNCTION AND URINARY CONTINENCE FOLLOWING RADICAL PROSTATECTOMY - RESULTS FROM THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC)

The Effect of Start and Stop Age at Screening on the Risk of Being Diagnosed with Prostate Cancer

Results from 22 years of Follow-Up in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial

The dilemmas of prostate cancer screening

Screening and Prostate-Cancer Mortality in a Randomized European Study

MP46-02 PROSTATE CANCER SCREENING NOMOGRAM PREDICTING 15-YEAR RISK OF CLINICALLY SIGNIFICANT PROSTATE CANCER, DEVELOPED USING COMPETING RISK ANALYSIS

PD35-04 COULD DIFFERENCES IN TREATMENT BETWEEN TRIAL ARMS EXPLAIN THE REDUCTION IN PROSTATE CANCER MORTALITY IN THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER?

Prospective evaluation of a new patient decision aid to enhance prostate cancer screening decision-making

The efficacy of prostate‐specific antigen screening: Impact of key components in the ERSPC and PLCO trials

Thromboembolic Complications in 3,544 Patients Undergoing Radical Prostatectomy with or without Lymph Node Dissection

Aktive Filter

Suchergebnisse filtern